Ziel: Bestimmung der Wertigkeit der Magnetresonanztomografie (MRT) bei 3 T zur Differenzierung zwischen organbegrenztem und kapselüberschreitendem Tumorwachstum beim Prostatakarzinom (PCa). Material und Methoden: Bei 38 konsekutiven Patienten mit histologisch gesichertem PCa erfolgte eine multiparametrische 3-T-MRT-Untersuchung mit endorektaler Spule. Zwei Radiologen mit 9 (A) bzw. 4 (B) Jahren Erfahrung in abdomineller und urogenitaler MRT-Bildgebung bewerteten die bildmorphologische Erkennbarkeit einer Kapselüberschreitung (ECE) bzw. Samenblaseninfiltration (SVI). Als Referenz diente die intraoperative Schnellschnittdiagnostik in den sechs Regionen apikal, dorsolateral und harnblasennah, jeweils beidseits sowie die postoperative Aufarbeitung des Prostatektomie-Präparats und der Samenblasen. Ergebnisse: Die histopathologische Auswertung ergab eine ECE in 15 von 222 Regionen (10 von 37 Patienten) und eine SVI in 8 von 74 Regionen (5 von 37 Patienten). Sensitivitäten, Spezifitäten und Genauigkeiten der Detektion einer ECE betrugen für Radiologe A/B 93 %/67 %, 92 %/95 % und 92 %/93 % pro Region bzw. 90 %/80 %, 74 %/ 82 % und 78 %/81 % pro Patient. Die entsprechenden Werte für die SVI lagen bei 80 %/100 %, 96 %/ 99 % und 95 %/97 %. Schlussfolgerung: Die MRT der Prostata stellt eine zuverlässige, nicht-invasive Methode zum lokalen Staging beim PCa dar. Kernaussagen: ▶ Die endorektale 3-T-MRT erreicht hohe Genauigkeiten beim lokalen Staging des Prostatakarzinoms. ▶ Die patientenbasierte Sensitivität zur Detektion eines extrakapsulären Tumorwachstums betrug 80 % und höher. ▶ Die entsprechende Spezifität zur Detektion eines organüberschreitenden Tumorwachstums (pT3) war hoch.
Introduction ! Magnetic resonance imaging (MRI) is widely accepted as the most accurate noninvasive diagnostic tool for the local staging of prostate cancer (PCa) [1] . Different studies on the accuracy of 1.5 T MRI for the local staging of PCa have reported average specificities higher than 80 %. Some studies suggest that 1.5 T MRI with an endorectal coil can provide specificities of up to 99 % in detecting extracapsular tumor growth (stage T3) of the disease [2] . On the other hand, the range of corresponding sensitivities, 14 -94 %, is very broad with an average value around 60 % [3, 4] . This finding may have limited the clinical use of 1.5 T MRI as a routine tool for staging, as previously remarked by Fütterer et al. [5] . The introduction of clinical 3 T MRI has led to a number of studies aiming to determine the value of 3 T imaging for PCa staging. The higher signal-to-noise ratio generally provides a better image quality and will potentially allow for more accurate staging. Some studies that have compared the use of a standard phasedarray coil at 3 T with that of an endorectal coil at 1.5 T, however, have shown that the former imaging technique is not necessarily superior in terms of local staging accuracy [6, 7] . Heijmink et al. have recently compared the use of phased-array and endorectal coils at 3 T and found that the latter seems to provide a clear benefit in terms of diagnostic image quality and staging accuracy [8] . It is presently difficult to assume an improved PCa staging accuracy for higher field strengths due to the very limited number of dedicated studies. Therefore, the aim of this study was to assess the sensitivity and specificity of an endorectal 3 T MRI examination in detecting extracapsular extension.
Materials and Methods

!
Patient characteristics
After obtaining IRB approval, 38 consecutive patients (February-June 2010) with histologically confirmed PCa underwent endorectal 3 T prostate MRI prior to radical prostatectomy. All patients gave written informed consent. 37 of them (mean age 65 years, range 53 to 75 years) were analyzed retrospectively and one patient was excluded because his urinary bladder opening was resected without prostatectomy. The general exclusion criteria were contraindications to MRI (e. g., pacemaker or cerebral metal clips), gadolinium-based MR contrast agents or endorectal coil insertion (e. g., prior anorectal surgery, inflammatory bowel disease or high anal sphincter tension), as well as severe claustrophobia. The median prostate-specific antigen (PSA) level was 13.5 ng/ml (range 3.7 -56 ng/ml) and the median postoperative Gleason Score (GS) was 7.0 (range 6 -9). MRI was performed 1 -16 days (mean 1.9 days) before prostatectomy. The mean time between transrectal ultrasound (TRUS)-guided biopsy and MRI was 55 days (range 11 -119 days) for all patients and 58 days (range 33 -114) for 10 patients with extracapsular extension. All patients underwent one TRUS-guided biopsy with a mean count of 11.6 (range 6 -27) tissue samples and an average of 4.0 (range 1 -12) of them being positive for PCa. The mean time between TRUS-guided biopsy and surgery was 57.6 days (range 12 -120 days) for 27 patients without ECE and 61.4 days (range 34 -115 days) for 10 patients with ECE. Patients were subdivided into three groups with low, intermediate and higher risk according to the D'Amico criteria (GS ≤ 6 and PSA ≤ 10 ng/ml, GS = 7 and PSA 10 -20 ng/ml and GS ≥ 8 or PSA ≥ 10 ng/ml).
MRI protocol
MRI was performed in a 3 T MRI unit (Magnetom Trio, Siemens Healthcare, Erlangen, Germany) using the combination of pelvic phased-array and endorectal coils (eCoil, Medrad, Pittsburg, PA) for signal acquisition. The endorectal coil was filled with 30 -40 ml of perfluorocarbon solution (Perfluorooctyl bromide, ABCR GmbH, Karlsruhe, Germany) to minimize susceptibility artifacts. Before the examination, all patients received an intravenous injection of either 40 mg butylscopolamine (Buscopan, Boehringer Ingelheim, Germany, in four patients) or 1 mg glucagon (Glucagen, Nordisk, Gentofte, Denmark, in 34 patients) to reduce peristalsis. Fast T1-weighted (T1w) localizer images were used to confirm the correct position of the endorectal coil and to define transverse slices orthogonal to the prostatic urethra. Morphologic imaging included a T2-weighted (T2w) fast spin-echo sequence (in-plane resolution IPR = 0.57 × 0.57 mm 2 , repetition and echo time TR / TE = 4400 -4600 / 126 ms, slice thickness ST = 3.0 mm, slice gap SG = 0.6 mm, 19 -22 slices, field of view FOV = 110 × 110 mm 2 , flip angle FA = 120 -135°) covering the whole prostate and the seminal vesicles in transverse, coronal and sagittal planes. Diffusion-weighted imaging was performed with a single-shot echo planar imaging sequence (IPR = 1.0 × 1.0 mm 2 , TR / TE = 3000 / 85 ms, ST = 3.0 mm, SG = 0.6 mm, 19 -22 slices, FOV = 250 × 250 mm 2 , FA = 90°) in transverse planes using b-values of 0, 50, 400 and 800 sec/mm 2 . Spectroscopic imaging was performed using an established prostate protocol based on a combination of point-resolved spectroscopy volume localization and 3 D chemical shift imaging covering the whole prostate in 8 slices [1] . Dynamic contrast-enhanced imaging (DCEI) was based on a transverse T1w sequence (20 time steps of 12 s each, IPR = 0.57 × 0.57 mm 2 , TR / TE = 4.7 / 1.7 ms, ST = 3.0 mm, SG = 0.6 mm, 19 -22 slices, FOV = 110 × 110 mm 2 , FA = 14°) following bolus injection of 15 -20 ml of contrast agent (Dotarem, Guerbet, Paris, France).
MRI evaluation
All patients were evaluated by two readers who had full access to the image data on a conventional radiological workstation (SIE-NET MV 1000, Siemens, Erlangen, Germany). The readers were blinded to the individual serum level of PSA, GS and the results of the histopathologic TNM classification but knew that all subjects had biopsy-proven PCa. Both readers had only limited prior experience in endorectal MRI interpretation of the prostate at 3T: Reader A (M.S.), a radiology specialist with 9 years of experience in abdominal and genitourinary MR diagnostics had read 40 endorectal prostate MRI cases, while reader B (J.F.), a resident in radiology with 4 years of general MR experience, had read 15 such cases. The presence of extracapsular extension (ECE) was based on five established T2w imaging criteria: 1. asymmetry of the neurovascular bundle, 2. obliteration of the rectoprostatic angle, 3. irregular bulging of the prostatic contour, 4. low signal intensity in the rectoprostatic fat, and 5. overt extracapsular cancer [9] . Infiltration of the prostate capsule was defined by a regularly delineated tumor contact with a length of at least 10 mm, similar to the criteria reported by Yu et al. [10] . If such a tumor contact showed irregular delineations or signal defects of the prostate capsule, even without hypointense T2w areas in the periprostatic fat or neurovascular bundles, this region was considered as extracapsular extension (ECE) [11] . Previously reported criteria in the literature were used to identify seminal vesicle invasion (SVI) and involved at least one of the following findings: disruption or loss of normal vesicle architecture, focal or diffuse areas of low signal intensity within the vesicles, asymmetric thickening or irregular shape of the vesicle wall as well as evident tumor at the prostate base extending into the seminal vesicles [12] . In addition, DWI and DCEI findings were used to rule out false-positive findings caused by hemorrhage or inflammation after TRUS-guided biopsy [1] . Hypointense T2w areas in the prostate or seminal vesicles in combination with high signal intensities in pre-contrast T1w images were associated with hemorrhage. Linear, wedge-shaped or hypointense prostate areas as well as wall thickening or hypointense lumina of the seminal vesicles on T2w without restricted diffusion or suspicious DCEI were regarded as (chronic) inflammation [12] . Image analysis was confined to six regions that are generally assumed to have the highest probability for ECE and SVI, namely the left and right sides of the apical, dorsolateral midgland and basal parts of the prostate ( • " Fig. 1 ) [13] . The readers first decided for (+) or against (-) the presence of ECE and SVI. In the (+) case, they were further asked to rate the confidence level of the above criteria (CL) on a five-point scale as clearly not applicable (CL = 1), probably not applicable (CL = 2), unclear (CL = 3), probably applicable (CL = 4) and clearly applicable (CL = 5).
Histopathological work-up
Immediately after surgical resection, the urologist inked the apical, dorsolateral midgland and basal portions of the prostate before sending it to the institutional pathology department. After separation and histological staining of the highlighted regions, frozen sections were intraoperatively analyzed by a senior pathologist (L.C.H. 13 years of experience in urogenital pathology) with respect to the status of the surgical margins. The remaining prostate sample was then processed according to a clinically established protocol [13] . This involved transverse, 4 to 5-mm thick step sections perpendicular to the prostatic urethra yielding about 10 tissue slices per prostate. Each slice was subdivided into four quarters resulting in approximately 40 sequentially labeled specimens per case. The final pathological report contained histological results of the analyses of both the fresh frozen samples (intraoperatively) as well as the prostatectomy specimens (postoperatively).
Correlation between MRI and histopathology
All intraoperative and postoperative histological results were used for radiologic-pathologic correlation. The results of the MRI-based reader ratings were compared to the histopathologic findings by a supervisor (J.O.), a resident in radiology with a total of 120 prostate MRI examinations, who was aware of all clinical data. The MRIbased reader findings were evaluated for each region where the pathologist identified extraprostatic extension. The MRI rating was counted as a true positive, if at least one of the CL was 4 or higher (CL ≥ 4), and as a false negative, if all scores were less than or equal to 3 (CL ≤ 3). Suspicious regions with CL ≥ 4 and no histopathological correlate were not necessarily counted as a false positive, but double-checked by the supervisor regarding potential errors in spatial mapping caused by gland deformation, fixationrelated shrinkage and misaligned tissue slicing. Following the "alternative neighbor correction" described by Turkbey et al., successful tumor mapping was assumed if respective findings were observed within immediately adjacent "neighbor" regions [14] . An extracapsular extension to the right dorsolateral midgland, for example, might effectively belong to a histopathological ECE of the right basal sample. If the supervisor located the MRI focus very close to the basolateral portion, which actually occurred in one case, the rating was still considered to be a true positive. Differences in the preoperative staging performance between both readers were analyzed with a one-way ANOVA with factor reader. Statistical analyses were performed using SPSS 18 (SPSS Inc., Chicago, IL) and a significance level of 5 %.
Results
!
Histopathology revealed extraprostatic extension into the periprostatic fatty tissue in 15 of the 222 (6.8 %) regions considered here (in 10 of 37 patients; 27 %) and into the seminal vesicles in 8 of the 74 potential regions (5 of 37 patients), respectively ( • " Fig. 2, 3 Table 5 summarizes the results of both uncorrected and alternative neighboring approaches. Differences between the readers were not significant, neither per region (p = 0.072) nor per patient (p = 0.556). Interobserver agreement κ was 0.72 per region and 0.89 per patient. Histopathology revealed low, intermediate and high-risk PCa in 7, 19, and 11 of 37 patients with average PSA levels of 6.2, 8.4 and 28.8 ng/ml and median GS of 6 (no range), 7 (range 6 -7) and 8 (range 6 -9), respectively. None of the low-risk (0 %), four [15] . This type of surgery carries the risk of damage to blood vessels and nerves that are responsible for urinary continence and erectile function, two important factors with regard to the patient's quality of life [16] . Only patients with organ-confined dis- 
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eases are eligible for surgical approaches sparing these sensitive structures [13] . It is therefore important to accurately stage PCa before radical prostatectomy, in particular with respect to extracapsular extension (pT3 stage). Diagnostic tools like digital rectal examination, PSA measurements, systematic TRUS-guided prostate biopsies, and meta-data in the form of nomograms [1] provide some clues to the local stage [13] , but are often poorly reliable. An accurate determination of the tumor extent before radical prostatectomy, however, is practically impossible with these techniques [1] . The clinical benefit of preoperative MRI of the prostate is discussed controversially. Although MRI is widely accepted as the most reliable method for the local staging of PCa [1], some authors argue that it has little influence on therapeutic decision making [17] . Although the impact of functional information on staging accuracy was beyond the aim of this study, we believe that the specificities without such information would have been lower. False-positive results from post-biopsy hemorrhage and inflammation could be ruled out by a systematical correlation of T2w with DWI and DCEI images. In two patients with confirmed ECE, 36 and 41 days after TRUS-guided biopsy, post-biopsy hemorrhage could be detected by a low T2w signal in combination with an increased precontrast T1w finding. The more experienced reader correctly related the signal changes to the TRUS biopsy and also detected extracapsular tumor growth near the respective regions. In one patient, hypointense T2w changes at the dorsolateral midgland level with corresponding high signals on T1w images were interpreted as post-biopsy hemorrhage without detecting capsule infiltration by the less experienced reader. Fütterer et al. have previously reported that the combined use of T2w and dynamic contrast-enhanced MR images may significantly improve staging performance, in particular for less experienced readers [19] . Therefore, we also believe that a further inclusion of DCEI data will generally help to draw the attention to cancerous areas. These preliminary results suggest that the staging accuracy of endorectal MRI is not necessarily low for readers with little experience in endorectal 3 T MRI. It should be noted, however, that the number of patients with extracapsular extension was relatively small here, which compromises the statistical power of the re-ported values, in particular the specificity. More confident findings need to be obtained from larger study groups. Minimal technical requirements and potential clinical benefit of MRI examinations for PCa staging are still discussed controversially. While a number of studies at 1.5 T have clearly shown a better staging performance with endorectal imaging, the variability between reported 1.5 T results is generally significant ( • " Table 6 ). Researchers also come to different conclusions depending on the individual risk of the patient [5, 9, 11, 22] . Roethke et al., for example, have recently found the benefit of presurgical endorectal MRI to be more pronounced in patients with a higher risk of pathologic T3 disease, in particular for intermediate and high-risk PCa. In these patients, the neurovascular bundle could potentially be spared during surgery if the disease is confined to the organ [22] . At the same time, Cornud and coworkers have stressed the need for highly specific local staging for such patients to ensure that they are not excluded from curative surgical treatment [11] . For patients with low-risk PCa, Cornud et al. see a benefit of higher image resolution in detecting even subtle extracapsular tumor growth (high sensitivity) [11] . We agree that false-negative results should be avoided in these patients to refer them to timely treatment instead of keeping them under active surveillance, for example. In that respect, however, our results at 3 T do not provide further evidence because none of our low-risk patients showed subtle extracapsular tumor growth. We believe that the higher signal-to-noise ratio makes endorectal imaging the preferred option, even at 3 T, although care must be taken to not misidentify subtle changes as potential T3 disease (false positives). The benefit for staging is also suggested by a 3 T study by Heijmink et al., who observed better performance with endorectal coils reaching sensitivities and specificities in the 70 -100 % range [8].
• " Table 6 gives an overview of studies on the local PCa staging accuracy of MRI at different field strengths both with and without the use of an endorectal coil. Owing to the large variety of study conditions, in particular with respect to patient groups, readers and methodology, it is generally difficult to evaluate the results independently. For 3 T studies without an endorectal coil, however, it can be observed that either the sensitivity [8, 20, 23] or specificity was found to be below 80 % [6] while both values were higher than 80 % [8, 18] in two studies with an endorectal coil, at least for experienced prostate MRI readers (3 years, 250 cases). The good local staging accuracy of 3 T MRI with an endorectal coil, with sensitivities and specificities for ECE and SVI detection largely above 80 %, is confirmed in this study. This work was generally limited by the retrospective design and the fact that both readers knew that patients had biopsy-proven PCa and were scheduled for prostatectomy at our Urology Department. Like similar studies ( • " In conclusion, these preliminary results provide additional evidence that the local staging of PCa at 3 T with an endorectal coil is a highly reliable technique to noninvasively detect extraprostatic tumor growth. More extensive studies will be needed to provide more reliable estimates of the predictive power of endorectal 3 T MRI and also further assess the impact of reader experience.
Clinical relevance of study ▶ Endorectal MRI at 3 T provides high accuracy for the detection of pT3 stage prostate cancer.
▶ MRI may potentially be an alternative staging method to more invasive techniques such as ultrasound-guided biopsy.
▶ Endorectal 3 T MRI assessment of extracapsular tumor growth may be particularly helpful for patients scheduled for nerve-sparing surgical treatment. 
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